PROTAC-mediated structure–function disruption of CD26: a therapeutic strategy for driver-negative non-small cell lung cancer
This study was funded by the Key Research and Development Project of Shaanxi Province (2023-YBSF-292), the opening foundation (M2022-3) from Key Laboratory of Optic-Electric Sensing and Analytical Chemistry for Life Science, Ministry of Education, Qingdao University of Science and Technology, the National Natural Science Foundation of China (82102976, 52203337), the Youth Top Talent Program (11301223010722) from Xi'an Jiaotong University, the Key Research and Development Project of Shaanxi Province (2024SF-ZDCYL-02-09) and Capacity Improvement Plan of Shaanxi Health Committee (2024PT-09).
Authors
- Yinjuan Huang (ORCID: https://orcid.org/0000-0003-4974-6818)
- Wenbo He (ORCID: https://orcid.org/0000-0003-4687-5622)
- Guangjian Zhang (ORCID: https://orcid.org/0000-0003-0888-5723)
- Qiuyu Gong (ORCID: https://orcid.org/0000-0001-7924-8890)
- Jizhao Wang (ORCID: https://orcid.org/0000-0002-5379-2481)
- Deqian Qiao
- Shan Gao (ORCID: https://orcid.org/0000-0003-1731-2249)
- Xingzhuo Zhu
- Jiaqi Huang (ORCID: https://orcid.org/0000-0002-6514-3075)
- Bohao Liu (ORCID: https://orcid.org/0000-0001-6921-3539)
- Rui Gao (ORCID: https://orcid.org/0000-0001-7502-1162)
- L Zhang
Institutions
- First Affiliated Hospital of Xi'an Jiaotong University (CN)
- Xi'an Jiaotong University (CN)
Publication Details
- Journal
- EBioMedicine
- Published
- 2025-11-17
- DOI
- https://doi.org/10.1016/j.ebiom.2025.106026
- Citations
- 3
- Primary Topic
- Peptidase Inhibition and Analysis
- Type
- article
- Field-Weighted Citation Impact
- 3.14